• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Crawley: ‘It’s personal to me’: A qualitative study of depression in young people with CFS/ME

slysaint

Senior Member
Messages
2,125
Just found out that EC is now a Professor
Crawley is a medical advisor to the Association of young people with ME, was Chair of the British Association for CFS/ME (BACME, 2007-2010). She set up the Royal College of Paediatrics and Child Health special interest group for CFS/ME, was on the guideline development group for the NICE guidelines published in August 2007 and the MRC CFS/ME expert working group (2009-2010).

I don't think we'll ever be rid of her.:depressed: (not-clinical)
 

Jan

Senior Member
Messages
458
Location
Devon UK
Just found out that EC is now a Professor
Crawley is a medical advisor to the Association of young people with ME, was Chair of the British Association for CFS/ME (BACME, 2007-2010). She set up the Royal College of Paediatrics and Child Health special interest group for CFS/ME, was on the guideline development group for the NICE guidelines published in August 2007 and the MRC CFS/ME expert working group (2009-2010).

I don't think we'll ever be rid of her.:depressed: (not-clinical)

How can someone with such involvement with the whole PACE scandal not be affected by the re-analysis? Was obtaining the PACE data a complete waste of time then? It's beginning to appear as if it's not going to make the slightest difference to anything in the UK.
 

Ysabelle-S

Highly Vexatious
Messages
524
How can someone with such involvement with the whole PACE scandal not be affected by the re-analysis? Was obtaining the PACE data a complete waste of time then? It's beginning to appear as if it's not going to make the slightest difference to anything in the UK.

I think the PACE trial scandal is on a slow burn. Meanwhile they're trying to shore up careers and funding for the foreseeable future.
 

slysaint

Senior Member
Messages
2,125
I found this in another HoC debate;
"
It’s the forgotten condition that no-one thinks is important. It affects everything. It’s exhausting, depressing and makes you feel angry and frustrated.
It robs you of the life you thought you were going to have, the one you planned with your family. It robs you of a sense of purpose. You can’t do what you want, when you want, it’s unpredictable.

Life has to be adapted and constantly changed. The drugs make you feel sick and depressed and have side effects as long as your arm. It becomes important not to look back at what is lost and make an effort every day to look forward and think positively. But it’s invisible."

The person speaking is actually suffering from arthritis. Do they get told 'you're depressed and it's all in your head', I think not.
 

slysaint

Senior Member
Messages
2,125
Thanks to a post on another thread (letter to the CMRC) I've only just found out about this person (Jane Colby of Tymes Trust). She seems to me to be a far more worth expert than EC on the whole subject:
http://www.tymestrust.org/pdfs/mecfsseidintro.pdf

as posted on other thread:
Just found this posted by Jane Colby of Tymes Trust.

A chain of emails between those involved with setting up the CMRC. (Scrub the letter idea then...........pointless? Back to the petition..........................

BEHIND THE SCENES: SETTING UP THE UK CFS/ME RESEARCH COLLABORATIVE (UK CMRC)
A Report from Tymes Trust: the inside story on the Collaborative. Our Report is based, not on speculation or conjecture, but on direct evidence from emails exchanged by the participants. We think this is key reading for the ME community. We are publishing the text here in case you have not seen it yet.

NB In the records of the meeting where 'harassment' of researchers was discussed, no mention was made of personal threats such as have been reported in the media. Freedom of Information (FOI) requests were listed as the most damaging type of 'harassment'.

Full Report follows: originally released August 2014

INTRODUCTION

When the UK CFS/ME Research Collaborative (UK CMRC) was set up in 2013, the Young ME Sufferers Trust declined to attend the launch, due to concerns we expressed in a Statement, the text of which is here:
http://www.tymestrust.org/txt/alert201305meawarenessday.txt

Our concerns continue. The following information is from 212 email chains and associated attachments received from an FOI request to the Medical Research Council (MRC).

We note:

In the run-up to the full formation and launch of the Collaborative, a
meeting was recorded by the Science Media Centre (SMC)'s outgoing head of Mental Health (details below). In attendance were key persons now involved with the Collaborative. Under their heading 'Harassment' (of researchers) they list:

* Freedom of Information Requests
* Complaints to the GMC and various institutions
* Parliamentary Questions

A series of Action Points include:

* 'Support4rs - Work with Peter White and Simon Wessely to develop
resources for dealing with harassment'
* 'SMC – Run a press briefing on biosocial illness to improve public
understanding.'

NB Two sets of written records are kept of Collaborative meetings; one for the Board, another for the public. This should be borne in mind when reading records that are placed online.
[We understand that this may have changed after our report was published.]

Timeline with numbered quotes for ease of use

The first section of emails below shows how Professor Stephen Holgate, Chair of what was initially called the UK ME/CFS Research Collaborative, initiated and facilitated discussions resulting in a
change of terminology, with 'CFS' now predominating.
The charities' views were overridden; however, they accepted the situation and still took part.

* On 12th January 2013, Professor Stephen Holgate, Chair of what was at that point called the UK ME/CFS Research Collaborative (UK MCRC) sent an email to Collaborative group members stating: “As you will know, we have firmed up the date and place for the Inaugural
Launch of the UK ME/CFS Research Collaborative (UK MCRC). I attach a list of people that I intend to approach as researchers or those interested in supporting research in the field …”
(quote 1)
* Professor Holgate then emailed Professor Simon Wessely with importance marked as ‘High’ and copied only to Dr Esther Crawley of Bristol University and Joe McNamara of the MRC. It read “Dear Simon, If you feel there is anything you can do to help in identifying
researchers or in other ways, I would be very grateful. Thank you so much. Kind regards, Stephen.” (quote 2)
* Simon Wessely replied “First of all, it looks very good…… can’t see many ommissions (sic). I would probably sprinkle one or two scientists/researchers not particularly connected with CFS into the mix myself. Experimental psychologist perhaps, joe, do you know one?....” Simon Wessely’s suggested researchers were redacted. (quote 3)
* Stephen Holgate replied “Wow! This is terrific, Simon – thanks so much. I will add your suggested names. Kindest regards, Stephen” (quote 4)
(NB At the end of January, Stephen Holgate sent an update on the issue of researchers to Collaborative group members (31st January 2013): “Please see attached list of research-interested people so far attending the launch… Could you see if there is anyone else we should include...?” (quote 5) The list of recipients
included Simon Wessely.)
* Again on Saturday 12th January, Stephen Holgate sent another email: ”To all: One point that I would like a view on is the terminology: CFS/ME or ME/CFS, NHS, NICE and MRC use
CFS/ME. I wish to be consistent so can I have a view from all please. I will then make any changes (including the name of the collaborative!)” (quote 6)
* Simon Wessely was on the list of recipients. He replied: “Thanks for asking. I think we should stick with CFS/ME frankly. Keeps it in line with MRC and NICE. Journals certainly only use CFS. USA doesn’t use ME at all. CFS/ME seems to be the best compromise.
Nervous that ME/CFS would alienate one or two researchers not actively involved in area but who you would like to see involved.” (quote 7)
* This view was endorsed by Peter White “…… I agree with Simon that CFS has to lead. The hybrid CFS/ME allows the broad church that encourages generalizable research, while allowing stratification where necessary.” (quote 8)
* Sonya Chowdhury, CEO of Action for ME (AfME) replied “ … my preference is that we use ME/CFS and I suspect if we were to ask members, there would be a preference for this form from them too. However, I am prepared to work with either as the importance here is
consistency and collaboration and if the general view differs, I will go with the majority.” (quote 9)
* The MEA stated a preference for ME/CFS but that they also were “happy to accept the majority view on this”. (quote 10)
* MERUK’s preference was also for ME/CFS, they added “we use ME/CFS as do the patient-based campaigning charities.” (quote 11)
* On 21st January Stephen Holgate emailed the group, “After undertaking a poll for preferences of a title, the CFS/ME terminology seems to be the option most wish to go for. It seems that the NHS, Research Councils and NICE use this terminology as do the majority
on Pubmed. I hope we can now accept this.” (quote 12)
· The Collaborative thus became the UK CFS/ME Research Collaborative (UK CMRC).

At the end of January a meeting was held at which 'harassment' of researchers was discussed:

The Medical Research Council (MRC) and the Science Media Centre (SMC) are two of the UK CMRC Observers. Ed Sykes, SMC Head of Mental Health, attends the meetings of the Executive
Board on behalf of the SMC, while Joe McNamara & Neha Issar-Brown attend on behalf of the MRC. The MRC contributed nearly £5000 to the launch of the Collaborative and have stated their
willingness to be involved in and contribute further both directly and in kind.
* On the 1st February 2013, an email was sent from the out-going Head of Mental Health at the SMC. It was a “write up of the main points to come out of” the ‘CFS’ meeting held at the Wellcome Trust the day before. (quote 13)
* “All the best with this for the future, I hope the launch of the research collaboration goes well and that it gets easier to do research in this field.” (quote 14)
* Those in attendance at this meeting had included UK CMRC members Peter White of QMUL, Joe McNamara and Carmel Turner of the MRC and Esther Crawley of Bristol University. Simon Wessely & Trudie Chalder of IOP, King’s College London were also in
attendance.

* Quotes 15-18 are taken directly from this meeting's records in the email of 1st February.
* (quote 15) Current situation:
- ‘Coming out’ about the harassment has led to increased support for CFS/ME researchers, for example, from colleagues who were not aware of the situation.
* (quote 16) Harassment
- Harassment is most damaging in the form of vexatious FOIs.
- Complaints are also causing problems. Researchers are still dealing with complaints about them to the GMC.
- House of Lords Debates on CFS/ME can result in Parliamentary Questions which often
require detailed responses
* (quote 17) ….. researchers are using strategies to reduce the impact of harassment and put the case for research into CFS/ME including:
- Learning about the FOI Act and using strategies to reduce time spent responding, eg putting minutes of meetings online
- Coming together as a research community to respond to criticisms eg the joint letter in response to criticisms of Simon Wessely receiving the John Maddox prize.
- Working with trusted journalists to cover the problems associated with CFS/ME research
- Esther Crawley and Stephen Holgate are establishing a research collaborative including researchers, charities and other interested parties. There will be a launch event on 22nd April.
* (quote 18) from Action Points
- SMC – run FOI Act brainstorm
- ALL – look for opportunities to publicise CFS/ME research and give background information about the condition
- Support4rs – work with Peter White and Simon Wessely to develop resources for dealing with harassment
- SMC – run a press briefing on biosocial illness to improve public understanding. Fiona Fox to get information from Trudie Chalder and Rona Ross-Morris.

Subsequent action by the UK CMRC can be seen in the context of these Action Points (above).

* One SMC ‘strategy’ to reduce ‘harassment' was to “put minutes of meetings online.”
Following the 22nd May 2013 meeting of the Executive Board of the UK CMRC Sonya Chowdhury emailed “Hi all – please find attached the minutes of our meeting and a summary for public consumption. I have deliberately made the summary detailed so that people don’t feel we’re only providing limited information…In the future, I would suggest that the summary is approved by the Chair and Vice Chair so that they can go up immediately after the meeting.” (quote 19)
- 3rd June, Sonya Chowdhury to group “As agreed we can now share the above summary [“CFSMERC minutes 23.5.13”] on websites etc. and the minutes are for the Board only. (quote 20)
- 11th October, Sonya Chowdhury to group “Hi All – please find attached: Chair-approved minutes of our meeting on Monday; Chair-approved summary notes of the meeting which will go on our website, as previously agreed.” (quote 21)
- 14th January 2014, Sonya Chowdhury to group “Attached are the chair-approved minutes (for the Board only) and the summary notes (for public consumption).” (quote 22)

* Re the SMC Action Point regarding “opportunities to publicise CFS/ME research and give background information about the condition” (reference quote 18); on 17th April Esther Crawley informed the Collaborative that the press release regarding the launch had been rewritten and “hopefully incorporates most of your comments. I hope this is now the final version.” (quote 23)
* She clarified that this press release concerned the launch of the Collaborative, and not the press conference, which was to take place separately. Journalists were sent a separate invitation to the press conference. She explained: “journalists will already have received this invitation from the SMC about the press conference (pasted below).” (quote 24)
* The press conference invitation ‘pasted below’ began – “Science Media Centre News Briefing – What? Chronic Fatigue Syndrome – unravelling the controversy” (quote 25)
- It stated “Chronic Fatigue Syndrome (CFS; also known as ME) is an incredibly controversial field, not just in terms of public perception, diagnosis and treatment but even for the very researchers trying to help who have experienced campaigns of
harassment from some patients.” (quote 26)
- It went on to state that “The disease affects over 600,000 people in the UK” inviting journalists to come along to find out amongst other thing “What imaging studies are showing us about overactive brains”. (quote 27)
- For further information journalists were asked to contact Dr Edward Sykes, Head of Mental Health at the Science Media Centre. (quote 28)
* Dr Charles Shepherd of the MEA objected in an email of the 17th April:
- 1. I still don’t believe it is sensible to drag the harassment campaign into the press reporting of the launch of the collaborative …I just don’t see what is going to be achieved by encouraging journalists to include this aspect in their reporting of the event. (quote 29)
- 2. Could we also include myalgic encephalomyelitis (or encephalopathy) in the title and CFS/ME elsewhere. (quote 30)
- 3. I don’t know what ‘overactive brains’ are in relation to ME/CFS. Sounds a bit like anxiety …. I don’t think this is a good term to be feeding to the press. (quote 31)
* The response from Esther Crawley was “Just to clarify – the SMC invitation was included [in her previous email] just to explain why we have done the press release as we have. It is not for public consumption. It has already gone out.” (quote 32)
* Further to the SMC Action Point regarding “opportunities to publicise CFS/ME research and give background information about the condition” (reference quote 18): on 12th March
2014, Esther Crawley emailed to the group: “There is a competition to present research to Parliament. The aim is to provide information about research to try and ensure funding is secure for next year. If successful the winners will have posters about projects with
demonstrable benefits in parliament at a reception on June 3rd this year.” (quote 33)
- “I have prepared an application (attached) with help from both Stephen and Peter for the CMRC. We have only 300 words to describe a “project” which has already had health benefits. Looking at previous successful applications, they expect very lay friendly descriptions of projects that tell a story. As it is only 300 words, I have included snippets about research that I am familiar with that has already had health benefits (the category I think we should submit under).” (quote 34)
- “Stephen has obviously helped me a lot with this. Although we have mentioned the harassment, this is part of the previous story and is to help identify what is new and different at the moment…..” (quote 35)
- “The deadline is Friday but I will need to submit it tonight …. So if you have any comments, can you let me know as soon as possible? Can you please copy Stephen in please?” (quote 36)
- The original draft of the 300 word description by Esther Crawley, Stephen Holgate & Peter White included “In the past, the CFS/ME researchers and charities have been divided, with researchers leaving the field because of personal attacks and funding
difficulties.” (quote 37)
- The final submission included: “…Research has been a powerful tool for change in the UK with a small amount of funding producing significant health benefits. For example, n children and teenagers, we have shown that it is common, occurs in primary school
children; is more common in those from socially disadvantaged families and is very treatable with excellent outcomes. In adults we have shown it is more common in UK ethnic minorities, described inequalities to accessing health care and shown which treatments are safe and effective. This research evidence-based approach has
encouraged more commissioners to provide services and helped clinicians to improve services, increasing the numbers of children and adults offered treatment.” (quote 38)

- After Esther Crawley sent the draft version out to the Collaborative for comment she sent another email to Stephen Holgate and Peter White: “As you can see – I have sent the form to the executive. I mentioned the harassment bit in the email because early feedback suggested this might be a problem with the charities (sigh).” (quote 39)

The launch of the UK CFS/ME Research Collaborative (UK CMRC) took place on April 22nd 2013.

The Young ME Sufferers Trust (Tymes Trust)
August 2014
Formatted Report for ease of use: http://bit.ly/1vSRhOI
 

Seven7

Seven
Messages
3,444
Location
USA
How can someone with such involvement with the whole PACE scandal not be affected by the re-analysis? Was obtaining the PACE data a complete waste of time then? It's beginning to appear as if it's not going to make the slightest difference to anything in the UK.
I think the association have to try different angles like Ethic or professional fraud persecution, you touched in an important point, this cannot be let go or we will be in the grasps of Psys for the foreseeable future. We cannot just let it go and the universe will fix it for us.
 

RogerBlack

Senior Member
Messages
902
This was a study she did last year. She's clearly trying to prove that ME/CFS in children is different to in adults.
This is also very disturbing, almost as if she were trying to create a completely different subset (ie paediatric CFS) and using data from abroad as well to add credence.

"This is the first study to show that children with CFS/ME present differently compared to adults with CFS/ME. Children and adolescents had less fatigue and better physical function, and were much less likely to have been given a diagnosis of comorbid illnesses, including depression and anxiety. Younger children were more likely to present with sore throat and were less likely to have sleep or memory problems, often considered cardinal symptoms in adults. Adolescents were more likely to present with cognitive and sleep dysfunction than were younger children, but less likely to present with tender .

At least some of this seems to reflect my experience with the condition changing over time.
I very rarely now have a sore throat, but I did at the beginning, and though it is hard to look back over the eons, it seems that my physical function must have been better shortly after onset.

It is deeply depressing that (for good reason) all possibly interesting results from these researchers must be treated so sceptically.